FY17 results

Results

Ascendas REIT posts 1.5% increase in 4Q DPU to 3.91 cents

SINGAPORE (Apr 23): The manager of Ascendas REIT (AREIT) has declared a 4Q18 DPU of 3.91 cents, 1.5% higher compared to the 4Q17 DPU of 3.852 cents.

Results

8Telecom narrows FY17 losses to $1.51 mil

SINGAPORE (Mar 15): 8Telecom International Holdings, the manufacturer and supplier of telecommunications products, announced that it has narrowed its FY17 losses to $1.51 million compared to $27.4 million in FY16.

Results

Golden Energy and Resources reports near-trebling of FY17 earnings to US$63 mil

SINGAPORE (Mar 9): Golden Energy and Resources (GEAR) saw its full-year earnings nearly treble to US$63.0 million ($82.9 million) for the FY17 ended December, from US$22.0 million a year ago.

Results

Hongkong Land posts 67% increase in FY17 earnings to US$5.6 bil on fair value of investment properties

SINGAPORE (Mar 8): Hongkong Land Holdings, the property group which is a member of the Jardine group, announced FY17 earnings increased by 67% to US$5.6 billion ($7.37 billion) compared to US$3.35 billion in FY16.

Broker's Calls

Attractive valuations keep China Jinjiang at 'add' despite earnings miss

SINGAPORE (Mar 8): CIMB is reiterating its “add” recommendation on China Jinjiang Environment Holdings (CJE) with a lower target price of 85 cents.

Broker's Calls

Ho Bee's stable recurring income and undervalued luxury properties keep it at 'buy'

SINGAPORE (Mar 5): Phillip Capital is maintaining its “accumulate” call on Ho Bee Land with a target price of $2.98.

Aviation & Engineering

Shanghai Pudong to drive China Aviation Oil's earnings growth

SINGAPORE (Mar 2): Phillip Capital is reiterating its “buy” recommendation on China Aviation Oil (CAO) with a target price of $2.00.

Broker's Calls

SAC's rating on Advancer Global unchanged before meeting with management

SINGAPORE (Mar 2): SAC Advisors is keeping its “buy” rating on Advancer Global with a target price of 36 cents.

Broker's Calls

Record FY17 for Singapore Medical Group with FY18 expected to be stronger

SINGAPORE (Mar 2): RHB is maintaining its “buy” call on Singapore Medical Group (SMG) with a target price of 68 cents, as the group’s turnaround is further validated by organic and inorganic growth.

Results

Top Global swings out of the red in 4Q on revenue surge

SINGAPORE (Mar 2): Top Global reversed out of the red with earnings of $1.4 million in the 4Q ended December, compared to losses of $11.3 million in the corresponding quarter last year.
×